New CSF biomarkers on the block
Abstract A growing number of cerebrospinal fluid biomarkers are now available to capture different aspects of Alzheimer's disease. People are increasingly aware that these biomarkers represent a real‐time reflection of pathological mechanisms that are ongoing in the brain. These novel markers c...
Main Authors: | , |
---|---|
Format: | Article |
Language: | English |
Published: |
Springer Nature
2016-09-01
|
Series: | EMBO Molecular Medicine |
Online Access: | https://doi.org/10.15252/emmm.201606801 |